Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. - Wikidata - awgldk - TriplyDB

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

http://www.wikidata.org/entity/Q35595386

about

Thrombin activation and liver inflammation in advanced hepatitis C virus infection Microcomputed tomography with diffraction-enhanced imaging for morphologic characterization and quantitative evaluation of microvessel of hepatic fibrosis in rats.Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis.Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study.Impact of antithrombin III on hepatic and intestinal microcirculation in experimental liver cirrhosis and bowel inflammation: an in vivo analysis.Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics.Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease.Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis.Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases.The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm.Viral cirrhosis: an overview of haemostatic alterations and clinical consequences Coagulation in hepatobiliary disease.New therapeutic paradigm for patients with cirrhosis.Review: Viral infections and mechanisms of thrombosis and bleeding.Management of portal vein thrombosis in liver cirrhosis.Future treatments of cirrhosis.VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C.The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection.Role of anticoagulant therapy in liver disease.A role for thrombin in liver fibrosis.The hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III.Haemostatic Profile of Patients with Chronic Liver Disease- its Correlation with Severity and Outcome Effects of aspirin and enoxaparin in a rat model of liver fibrosis.The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source.CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis.Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C.Coexistent Ipsilateral Internal Carotid Artery Occlusion and Cerebral Venous Thrombosis in Hepatitis C.Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients.von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.Benign external compression of the inferior vena cava associated with thrombus formation.Thrombin and factor Xa link the coagulation system with liver fibrosis.Protein C Deficiency in Chronic Hepatitis C: Correlation With Histological Extent of Liver Fibrosis.

P2860

Q26749460-0891BCA8-4C11-460B-9CC3-A90A42861768 Q27303571-C34C929C-4682-48F6-B71E-EC7CA7163D46 Q27478140-9E3E09E3-223C-469C-8636-4C252211643A Q34012609-F1E48595-174B-442C-9029-EDD1570E72B9 Q34013076-63FBA12B-C4C0-4B72-8246-39386B247DC7 Q34038709-9142A5F1-9D17-422A-A9AD-844812D03536 Q35064494-6023D90E-6548-4ADA-B6A9-2CB88BAD4DFF Q35235447-587531F4-8EED-47C6-A367-162519DF3F82 Q35597990-D942C47B-2FD7-4124-8F3E-57C76744CA82 Q35613902-58FF6503-10D7-47FB-9370-B7AAE6910D37 Q35777683-7182D0C5-1ECE-45CE-BEFC-73FD505AEE41 Q35928746-2EED2764-5B04-4CF4-9E33-86BF4FE4FE6B Q37646912-E329F56E-4EB9-4728-A943-F54917C80F9D Q37854462-4738353D-C6E6-4BD0-AF58-78E879408D97 Q37982415-654BB810-285B-45A7-8752-6F3FD43E13A9 Q38021413-17FA091E-1DEF-45B1-B8E3-02072BFFCA01 Q38038832-8E73CCF2-0280-4463-968F-9DFBB7C4B167 Q38200854-56744E4A-CCE8-4DD9-8CC6-FAB7F37F7609 Q38218607-03F0823C-ECB9-4E66-BCD4-9693004F6CEE Q38863591-CC8FB089-D2D7-4F4B-86B9-F1FB1A74F2E9 Q40037618-7B08AE1C-B33E-49DB-8F0B-83861BD141E1 Q40707344-B6739245-E0EA-4DEC-9F54-D24BE81ECA02 Q41791167-B92EC329-8DAF-405A-BA16-E673D7243992 Q41910544-C712515E-AF1A-450A-AE29-EFF741F290E9 Q42367006-83D58E25-63B4-4308-92ED-2D60FFBAD63F Q42695257-62669A6B-E2AC-4F4A-9A86-8959B00C8546 Q43036723-B3A9B96B-B4E3-4B9B-B127-0C19A25CB1B1 Q43159403-E3D2B666-A248-4D0B-BC2C-6A1C4D0B9515 Q44703656-0AAA2A16-52F8-40DF-B0C2-6B8B8CD8C6E4 Q47551591-1678E3C3-7B76-4C45-9B94-649C2D3DA7AD Q50477058-78D80E0E-2B32-4DF6-9675-E59EFEDBE772 Q51344051-72ABC9E1-3C90-475A-8DFA-ADC9A787D2A3 Q53584306-1BB54076-28B7-4F43-8BDD-1BBB6B1B4E88 Q54996240-B0B30599-D06E-4948-A422-1CB7DA28329E Q55059117-F5DE6870-07E8-4D05-8D0E-86CB60E5F845

P2860

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

http://www.wikidata.org/entity/Q35595386

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

@ast

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

@en

type

label

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

@ast

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

@en

prefLabel

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

@ast

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

@en

P1433

Q35595386-22ADFF47-CFCE-4113-B70B-37F590E79B02

P1476

Q35595386-51317EEA-8AD8-4568-A9CE-A76A938EC5D9

P2093

Q35595386-15E1F236-D809-4E5B-B746-C8821DF36C44

Q35595386-39C8731E-6522-448F-B35D-BDC76D11EAA4

Q35595386-69DA6D11-40AD-4E4E-9417-9D35A83B3F15

Q35595386-8B773600-721D-4C44-BEB2-FA26CD342391

Q35595386-8F2D9622-37D8-4CE7-B9D9-D886E1823F11

Q35595386-8F53D8E4-2F79-4D78-9CE9-80A0C61902A3

Q35595386-AFE09E5C-5836-49BB-94FA-03B46C73B1BD

P2860

Q35595386-0156B32D-0053-42D5-B856-D8EF5E597397

Q35595386-33319341-EB76-4DDD-B1EB-CAD3AA438069

Q35595386-3DB0D81D-272A-4A82-BCF8-303A29DEE82C

Q35595386-47E9F3A5-EBEB-4AAE-AEDC-D96AAD0DFA01

Q35595386-57D3EA56-E8BE-4F35-B056-78EE03FF6C7A

Q35595386-6F6EE820-DF71-4F10-B3C8-A6026BCBFE99

Q35595386-7393B3D6-33B1-416F-8CF5-F49E5E147EB5

Q35595386-76FA4C4D-4992-485E-983C-C1D67C24A441

Q35595386-7D3F89D8-DDEC-4C2D-8826-7FC05B2B8E28

Q35595386-A4AB9305-727B-49E0-80BC-F61DB9F74584

P304

Q35595386-395C65EF-DD00-4ADB-A96D-BEF25C87B7C2

P31

Q35595386-854915F3-1E0C-46E0-8025-6D2A7B23168D

P356

Q35595386-915D854C-9843-4B17-8FE5-778401DB4DC6

P407

Q35595386-415883CC-2853-46B9-AFF2-4F5850AA539F

P433

Q35595386-21BFC002-506C-4AA3-ACDB-58ABB2C4A207

P478

Q35595386-3639DC18-6363-45FC-8923-7F991B511D37

P577

Q35595386-E8B7FA4A-8878-424D-8CFF-9B2B3CBC6F3B

P5875

Q35595386-69A15266-CD64-4F89-B16B-55026201C7DE

P698

Q35595386-ED77520C-15FA-4E97-9CFE-20BA64926FD4

P932

Q35595386-23A1A9AB-B959-478C-A68D-7C9354FB4F25

P356

P1433

P1476

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

@en

P2093

E Andrioti

http://www.w3.org/2001/XMLSchema#string

E Cholongitas

http://www.w3.org/2001/XMLSchema#string

E Papakonstantinou

http://www.w3.org/2001/XMLSchema#string

G V Papatheodoridis

http://www.w3.org/2001/XMLSchema#string

I Kontopoulou

http://www.w3.org/2001/XMLSchema#string

K Petraki

http://www.w3.org/2001/XMLSchema#string

S J Hadziyannis

http://www.w3.org/2001/XMLSchema#string

P2860

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Histological grading and staging of chronic hepatitis

Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome

Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome.

Venous thrombosis: a multicausal disease.

New aspects of hepatic fibrosis.

Natural history and prognostic factors for chronic hepatitis type B

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

Viral infections and antiphospholipid antibodies.

The regulation of hemostasis: the protein C system.

P304

404-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.52.3.404

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275391280

http://www.w3.org/2001/XMLSchema#string

P698

12584224

http://www.w3.org/2001/XMLSchema#string

P932

1773539

http://www.w3.org/2001/XMLSchema#string